Pakistan Institute of Living and Learning Report issue

Academic/Hospital Phase 2 Phase 3

Organization Overview

First Clinical Trial
2018
NCT03435744
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Pakistan Institute of Living and Learning | Pakistan Institute of Living & Learning